2023
DOI: 10.1016/j.mayocpiqo.2023.04.009
|View full text |Cite
|
Sign up to set email alerts
|

Contemporary Monoclonal Antibody Utilization in Glomerular Diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 100 publications
0
1
0
Order By: Relevance
“…Cyclophosphamide (CP) is a cytotoxic chemotherapy and alkylating drug that is used in the treatment of various cancers, [ 1 ] autoimmune diseases such as glomerulonephritis, [ 2 ] and also in the control of organ rejection after transplantation. [ 3 ] CP is a prodrug that is metabolized in the body into acrolein and phosphoramide mustard as bioactive metabolites, which are toxic.…”
Section: Introductionmentioning
confidence: 99%
“…Cyclophosphamide (CP) is a cytotoxic chemotherapy and alkylating drug that is used in the treatment of various cancers, [ 1 ] autoimmune diseases such as glomerulonephritis, [ 2 ] and also in the control of organ rejection after transplantation. [ 3 ] CP is a prodrug that is metabolized in the body into acrolein and phosphoramide mustard as bioactive metabolites, which are toxic.…”
Section: Introductionmentioning
confidence: 99%